Philip Liang, Director at Vicarious Surgical Inc. (RBOT), bought 74,300 shares at $2.32 ($172K) on 2023-03-28, disclosed to the SEC on 2023-03-30.
Open-market purchase of $172k RBOT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| RBOT | BUY | 2023-04-11 | $13K | — | Filing → |
| RBOT | BUY | 2023-04-10 | $6K | — | Filing → |
| RBOT | BUY | 2023-03-29 | $153K | — | Filing → |